DONATE TO UROPAC


Treatment
General Brochure
Provider Broch.













 

 

 

 

 

September 9, 2008
The Winery at The District
2647 Park Avenue, Tustin CA
TEL: 714-258-7600

WHO ATTENDED

6:30 pm: Welcome Reception

7:00 pm: Dinner & Speaker


 

Speaker: Dr. Craig V. Comiter, M.D., Stanford University Medical Center
   
Topics: "Defining a Treatment for Overactive Bladder"



Education
MD: 1992, Harvard Medical School, Boston, MA
Residencies: 1992-1994, Brigham & Woman's Hospital, Boston, MA

1994-1998, Harvard Program in Urology, Boston, MA
Fellowship 1998-1999, Neurourology and Female Urology, University of California-Los Angeles, Los Angeles, CA


Clinical Specialties
Urology, Female Urology and Urodynamics

Board Certifications
American Board of Urology

Research
I am involved in several clinical studies. I currently am evaluating two novel and minimally invasive surgical techniques for urinary incontinence: an incisionless sling for female stress incontinence, and a male sling for post-prostatectomy incontinence. In addition, I am conducting a clinical trial of sacral neuromodulation for the treatment of interstitial cystitis and how it affects the urinary symptoms, as well as the chronic pelvic pain associated with the illness.

I also am involved in a multi-center study of a new implantable nerves stimulator for the treatment of urinary urgency and urinary urgency incontinence. In addition, I am involved in a novel treatment for pelvic pain and interstitial cystitis, using an implantable neural stimulator. I am part of a multi-center study of a new injectable substance for the non-operative treatment of female stress incontinence, and in a multi-center study of a new once-daily oral medication for overactive bladder. Additionally, in collaboration with my urodynamic nursing staff, we are evaluating the utility of new and useful urodynamic techniques for the evaluation of voiding dysfunction. At the VA Medical Center, I am an investigator for the study of the affect of selenium on prostate cancer progression and prevention. Finally, I am principal investigator for a new type of sling procedure for urinary incontinence following prostate cancer surgery.

Currently, I save several exciting basic science research projects, including a novel treatment for interstitial cystitis, and 3 new treatments for bening prostatic enlargement and overactive bladder.

Recently, I served as principal investigator for a NIH-funded study regarding the treatment of chronic prostatitis. I was also the lead investigator for a new type of sling material for female bladder neck suspension surgery. I was also the principal investigator for a research study involving a new type of muscarinic receptor blocker for the treatment of overactive bladder and urinary incontinence.

 

Meeting Fees
No charge to:
Members (in good standing)
Residents
$30 Fee to:
Senior Members
Health Professionals
Spouse/Guests
Out of Area Doctors
Orange County Non-Members:
click for Membership Information
 
 
Copyright 2008 (C) Orange County Urological Society


Thanks to the following companies for their ongoing support of our programs:

http://www.pfizer.com


http://www.aventispharma-us.com/Home.jsp